Matches in Wikidata for { <http://www.wikidata.org/entity/Q85237090> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q85237090 description "article scientifique publié en 2015" @default.
- Q85237090 description "artículu científicu espublizáu en mayu de 2015" @default.
- Q85237090 description "im Mai 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85237090 description "scientific article published on 26 May 2015" @default.
- Q85237090 description "wetenschappelijk artikel" @default.
- Q85237090 description "наукова стаття, опублікована в травні 2015" @default.
- Q85237090 name "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 name "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 type Item @default.
- Q85237090 label "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 label "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 prefLabel "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 prefLabel "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 P1433 Q85237090-7276FDE4-68B9-4102-BC58-5480F96A9041 @default.
- Q85237090 P1476 Q85237090-660CEC48-E9AF-4A21-ADB4-9D42F3C43683 @default.
- Q85237090 P2093 Q85237090-08B2CAAE-260F-4CDA-9ED4-6F881404D630 @default.
- Q85237090 P2093 Q85237090-4B5DF8CA-BDFC-459C-9F5B-C39AD8D78CB3 @default.
- Q85237090 P2093 Q85237090-4DE0D867-A590-4CF5-BC3C-898C69C28284 @default.
- Q85237090 P2093 Q85237090-65650839-B4BB-4804-A9ED-5E918AF54193 @default.
- Q85237090 P2093 Q85237090-A4A70832-5CB1-4E33-986C-B767D2778A83 @default.
- Q85237090 P2093 Q85237090-A8279432-2817-40CD-B41F-C7C7142E1277 @default.
- Q85237090 P304 Q85237090-9FF45873-99F4-4642-9BC0-E8335085EB6B @default.
- Q85237090 P31 Q85237090-6BC11B1A-114C-4142-A97E-03A9252E7298 @default.
- Q85237090 P356 Q85237090-5326FAC0-005A-4958-A21C-54998F6A49D9 @default.
- Q85237090 P433 Q85237090-9A8CAF01-C546-4CD9-8F24-6BAE5B26065B @default.
- Q85237090 P478 Q85237090-0F227F8F-CECD-43E5-AE53-81736C7CBCD7 @default.
- Q85237090 P50 Q85237090-96DA646D-3F3D-4FC0-AB6E-A49E10F768ED @default.
- Q85237090 P577 Q85237090-A1334222-6B79-404B-9AE0-ECB0D16AE500 @default.
- Q85237090 P698 Q85237090-0053E7F1-60E7-4070-9165-105FC7357F5A @default.
- Q85237090 P356 J.IJPHARM.2015.05.054 @default.
- Q85237090 P698 26022889 @default.
- Q85237090 P1433 Q6051539 @default.
- Q85237090 P1476 "Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin" @default.
- Q85237090 P2093 "Christos Reppas" @default.
- Q85237090 P2093 "Hisahi Mimura" @default.
- Q85237090 P2093 "Ryosaku Sakamoto" @default.
- Q85237090 P2093 "Satoshi Kitamura" @default.
- Q85237090 P2093 "Tomokazu Tajiri" @default.
- Q85237090 P2093 "Yukihiro Ozaki" @default.
- Q85237090 P304 "368-374" @default.
- Q85237090 P31 Q13442814 @default.
- Q85237090 P356 "10.1016/J.IJPHARM.2015.05.054" @default.
- Q85237090 P433 "1-2" @default.
- Q85237090 P478 "490" @default.
- Q85237090 P50 Q75360715 @default.
- Q85237090 P577 "2015-05-26T00:00:00Z" @default.
- Q85237090 P698 "26022889" @default.